Pancreatic Cancer Research

ResearcherTaipei Medical University HospitalActive in the last 2 years

Jeng-Fong Chiou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5274-9131; OpenAlex author ID A5053323336, A5110015940, A5110444855. Sources: ClinicalTrials.gov.

Their work

Papers
3
Trials
1
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2018: 1 trial · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Survival benefit of particle chemoradiotherapy in locally advanced unresectable pancreatic cancer: a systematic review and meta-analysis. Co-author DOI 10.1177/17562848261465516↗
  2. Role of Neoadjuvant Chemoradiation Therapy for Resectable and Borderline Resectable Pancreatic Adenocarcinoma-A Systematic Review and Meta-Analysis. Co-author DOI 10.1016/j.ijrobp.2025.02.037↗
  3. Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal a… Co-author DOI 10.1016/j.ejca.2022.01.030↗

Trials 1

  1. Therapeutic Response Evaluation by CTC Expansion System Study chair NCT04972461↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Long‐Sheng Lu · 2 shared papers, 2022–2025 · strength 0.42
  2. Hsin‐Lun Lee · 1 shared paper, 2026 · strength 0.32
  3. I‐Chun Lai · 1 shared paper, 2026 · strength 0.32
  4. Cheng-Shien Shieh · 1 shared paper, 2026 · strength 0.32
  5. Hongyan Wu · 1 shared paper, 2025 · strength 0.30
  6. Hui-Ju Ch’ang · 1 shared paper, 2025 · strength 0.30
  7. Long-Sheng Lu · 1 shared trial, 2018 · strength 0.26
  8. Shin‐E Wang · 1 shared paper, 2022 · strength 0.11
  9. Shih‐Ming Hsu · 1 shared paper, 2022 · strength 0.11
  10. Yi‐Ming Shyr · 1 shared paper, 2022 · strength 0.11
  11. Yuan‐Hung Wu · 1 shared paper, 2022 · strength 0.11
  12. Chung‐Pin Li · 1 shared paper, 2022 · strength 0.11
  13. Yee Chao · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.